Evidence map›Paper›PMID 38019344›Full record

ReviewCurrent osteoporosis reports2024

Practical Compass of Single-Cell RNA-Seq Analysis.

Hiroyuki Okada, Ung-Il Chung, Hironori Hojo

Erratum issuedAbstract readReview
In one paragraph

Review in Current osteoporosis reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Advances in Spatial Transcriptomics in Bone.Current osteoporosis reports · 2026
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Hiroyuki OkadaCenter for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, 113-8655, Japan. hokada-tky@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-4217-1548
Ung-Il ChungCenter for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Hironori HojoCenter for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, 113-8655, Japan.

Funding

JSPS KAKENHI JP 22H04925 (HOJSPS KAKENHI JP 22KK0272JSPS KAKENHI JP 23K15736 (HO)JSPS KAKENHI PAGS ver.2)Mochida Memorial Foundation for Medical and Pharmaceutical Research 2022Takeda Science Foundation 2022
6 · The paper itself

Abstract

purpose of reviewThis review paper provides step-by-step instructions on the fundamental process, from handling fastq datasets to illustrating plots and drawing trajectories. RECENT

findingsThe number of studies using single-cell RNA-seq (scRNA-seq) is increasing. scRNA-seq revealed the heterogeneity or diversity of the cellular populations. scRNA-seq also provides insight into the interactions between different cell types. User-friendly scRNA-seq packages for ligand-receptor interactions and trajectory analyses are available. In skeletal biology, osteoclast differentiation, fracture healing, ectopic ossification, human bone development, and the bone marrow niche have been examined using scRNA-seq. scRNA-seq data analysis tools are still being developed, even at the fundamental step of dataset integration. However, updating the latest information is difficult for many researchers. Investigators and reviewers must share their knowledge of in silico scRNA-seq for better biological interpretation. This review article aims to provide a useful guide for complex analytical processes in single-cell RNA-seq data analysis.

Indexed as

Sequence Analysis, RNASingle-Cell AnalysisCell DifferentiationFracture HealingHumansOsteoclastsRNA-SeqSingle-Cell Gene Expression AnalysisSoftwareComputational analysisDry analysisPractical compassSingle cell RNA-seqTranscriptome

Identifiers

PMID38019344
PMCPMC11420265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.